The trial found that the drug amiloride can treat multiple sclerosis
Release date: 2007-12-03 A recent study suggests that amiloride, a long-standing medication for high blood pressure, may hold promise as a treatment for multiple sclerosis (MS). Researchers in the UK have discovered that this drug could play a key role in managing the condition, based on findings from animal experiments. Multiple sclerosis is an autoimmune disorder where the body's immune system mistakenly attacks its own nerve cells. One of the underlying factors is the buildup of excess calcium inside nerve cells, which can damage the protective myelin sheath surrounding them. This damage leads to a range of neurological symptoms and progressive disability. According to a report published in *Nature Medicine*, scientists at the University of Oxford found that amiloride can block the accumulation of calcium in nerve cells, thus preventing further damage to the nervous system. The drug has been used for years to treat hypertension, making it a potentially viable candidate for repurposing in MS therapy. Lead researcher Lars Fogel emphasized that if further clinical trials confirm the effectiveness of amiloride in humans, it could significantly speed up the development of new treatments for MS patients. Currently, the team is working on determining the right dosage for human use and plans to start clinical trials in the coming year. This breakthrough offers hope for those affected by MS, as it opens up a new avenue for treatment using an already available drug. With more research needed, the potential of amiloride in treating this debilitating disease continues to be explored with great interest. ——Midi Medical Network Medical Equipment,Treatment For Facial Rejuvenation,Blood Plasma Centrifuge Machine,Dull Roughness Improvement Changzhou Timerein Biotechnology Co. , Ltd. , https://www.timereinbiotech.com